BioSpace News Archive

Elligo Health Research is proud to welcome Vice President, Healthcare Partnerships Katie Eyestone, Chief People Officer Kathleen Fairall, and Vice President, Practice Success Vanessa Watson to its leadership team.

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that it has strengthened intellectual property rights for its anti-interleukin-7 receptor (IL-7R) antagonist OSE-127/S95011 through the granting of a first patent by the European Patent Office (EPO). The patent covers the product and its therapeutic applications in autoimmune and inflammatory diseases through 2037.

Sanara expects to use the net proceeds from the offering to expand its salesforce and for further development of its products, services and technologies pipeline, clinical studies and general corporate purposes, including working capital.

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has closed on its previously announced sale to institutional investors of an aggregate of 24,906,134 shares of its common stock and warrants to purchase up to an aggregate of 12,453,067 shares of common stock

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs,

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that Mike Raab , president and chief executive officer of Ardelyx, will participate in a fireside chat at the 10 th Annual SVB Leenik Global Healthcare Conference

Solution will provide new omnichannel marketing opportunities for retailer and its advertiser partners, and further increase consumer choice in saving with Quotient-powered promotions.

Nascent Biotech, Inc. a clinical-stage biotech company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is excited to announce the publication of strong In-Vitro study results from its research collaboration with Syracuse University.

Havn Life Sciences Inc., announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately.

MedAvail Holdings, Inc. a technology-enabled pharmacy company, announced preliminary financial and operational results for the fourth quarter and full year 2020.